首页> 外国专利> Method for therapy prediction in tumors having irregularities in the expression of at least one VEGF ligand and/or at least one ErbB-receptor

Method for therapy prediction in tumors having irregularities in the expression of at least one VEGF ligand and/or at least one ErbB-receptor

机译:在具有至少一种VEGF配体和/或至少一种ErbB受体表达不规则的肿瘤中预测治疗的方法

摘要

The present invention is related to a method for predicting a clinical response of a patient suffering from or at risk of developing a neoplastic disease towards a given mode of treatment, said method comprising the steps of:a) obtaining a biological sample from said patient;b) determining, on a non protein basis, the expression level of at least one gene encoding for a ligand from the Vascular endothelial growth factor (VEGF) family and of and of at least one gene encoding for a receptor from the ErbB-family, or a gene co-expressed therewith, in said sample,c) comparing the pattern of expression levels determined in (b) with one or several reference pattern(s) of expression levels; andd) predicting therapeutic success for said given mode of treatment in said patient or implementing therapeutic regimen targeting the signalling pathway of said ligand and/or receptor is related to in said patient from the outcome of the comparison in step (c).
机译:本发明涉及一种预测患有肿瘤性疾病或有发展成肿瘤性疾病风险的患者对给定治疗模式的临床反应的方法,所述方法包括以下步骤:a)从所述患者获得生物样品;b)以非蛋白质为基础,确定至少一种编码来自血管内皮生长因子(VEGF)家族的配体的基因和至少一种编码来自ErbB家族的受体的基因的表达水平,或与之共表达的基因,在所述样品中,c)将(b)中确定的表达水平的模式与一种或几种参考表达水平的模式进行比较;和d)根据步骤(c)中的比较结果,预测所述患者中所述给定治疗模式的治疗成功或靶向所述配体和/或受体的信号传导途径的治疗方案与所述患者中的治疗相关。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号